Invitrogen™ Human BCAR3 Synthetic Peptide

Ref.: BL-RE-176419Manufacturer ref.: PEP-1467 50 μg
€149.00 excl. VAT

BCAR3 Synthetic Peptide, PEP-1467, from Invitrogen.

Gene ID (Enter)
8412
Species
Human
Purification method
Purified
Accession number
O75815
Common name
Human BCAR3
Brand
Invitrogen

BCAR3 Synthetic Peptide, PEP-1467, from Invitrogen.

BCAR3 Synthetic Peptide, PEP-1467, from Invitrogen.

Breast tumors are initially dependent on estrogens for growth and progression and can be inhibited by anti-estrogens such as tamoxifen. However, breast cancers progress to become anti-estrogen resistant. Breast cancer anti-estrogen resistance gene 3 was identified in the search for genes involved in the development of estrogen resistance. The gene encodes a component of intracellular signal transduction that causes estrogen-independent proliferation in human breast cancer cells. The protein contains a putative src homology 2 (SH2) domain, a hall mark of cellular tyrosine kinase signaling molecules, and is partly homologous to the cell division cycle protein CDC48.

Species

Species: Human.

Conservation

Storage: -20°C.

Formulation

Concentration: 200 μg/mL.

Regulatory status

Research only (RUO).

Packaging

Packaging: 50 μg.

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)15225379
Specifications
Gene ID (Enter)8412
SpeciesHuman
Purification methodPurified
Accession numberO75815
Common nameHuman BCAR3
Concentration200 μg/mL
DescriptionSynthetic Peptide
FormatLiquid
FormulaPBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
For use with (application)Blocking Assay, Control
Gene symbol(s)BCAR3
LyophilizedNo
Product typePeptide
Quantity50 μg
Regulatory statusRUO - research use only
Storage and shipping
Content and storage-20°C
Conservative0.02% sodium azide
Storage stampPBS

Origin and customs

Manufacturer ref.PEP-1467
Country of originUnited States
HS customs code3824 99 92 00
A question or a specific configuration?
Contact us for a quote.